Poly(N‐methyl‐N‐vinylacetamide): A Strong Alternative to PEG for Lipid‐Based Nanocarriers Delivering siRNA (Adv. Healthcare Mater. 8/2024)
Manon Berger,François Toussaint,Sanaa Ben Djemaa,Erik Maquoi,Hélène Pendeville,Brigitte Evrard,Christine Jerôme,Jeanne Leblond Chain,Anna Lechanteur,Denis Mottet,Antoine Debuigne,Géraldine Piel
DOI: https://doi.org/10.1002/adhm.202470052
IF: 10
2024-03-28
Advanced Healthcare Materials
Abstract:Lipid Nanoparticle In article 2302712, Denis Mottet, Antoine Debuigne, Géraldine Piel, and co‐workers display a lipid nanoparticle (LNP) designed for siRNA delivery, featuring a poly(N‐methyl‐N‐vinylacetamide) (PNMVA) coating. The latter prevents protein corona formation, enhances cell uptake, enables endosomal escape, and significantly reduces antibody‐mediated immune response and systemic pro‐inflammation. As DSPE‐PEG alternative, DSPE‐PNMVA enhances the efficacy of lipid‐based carriers by mitigating the dilemma effect, reducing immunogenicity, and maintaining comparable stealth and toxicity properties for improved siRNA delivery.
nanoscience & nanotechnology,engineering, biomedical,materials science, biomaterials